Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04YXB
|
|||
| Former ID |
DNC013389
|
|||
| Drug Name |
2-phenyl-1,8-naphthyridine
|
|||
| Synonyms |
2-phenyl-1,8-naphthyridine; CHEMBL235396; SKVWGHJCDNDXAG-UHFFFAOYSA-N; SCHEMBL5309600; 1,8-Naphthyridine, 2-phenyl-; ZINC28826013
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H10N2
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)C2=NC3=C(C=CC=N3)C=C2
|
|||
| InChI |
1S/C14H10N2/c1-2-5-11(6-3-1)13-9-8-12-7-4-10-15-14(12)16-13/h1-10H
|
|||
| InChIKey |
SKVWGHJCDNDXAG-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis and SAR comparison of regioisomeric aryl naphthyridines as potent mGlu5 receptor antagonists. Bioorg Med Chem Lett. 2007 Dec 1;17(23):6525-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.